| Literature DB >> 27106479 |
Hae Tha Mya1, Hui Ming Tay2, Shien Wen Gan3, Shilpa Surendran2, Shu Hui Yeang4, Cynthia Ciwei Lim3, HuiLin Choong3, Lai Heng Lee2, Heng Joo Ng2.
Abstract
Increasing awareness and availability of tests for anti-PF4/heparin complex antibodies has raised concerns about indiscriminate testing and inappropriate diagnosis of heparin-induced thrombocytopenia. A retrospective review of HITS testing at a large tertiary centre was performed to determine test patterns and incidence of HITS. Records of anti-PF4 tests over 4 years were reviewed. Positive results were matched against patient medical records and records of heparin utilisation for the diagnosis of HITS. Total of 33,308 patients (9.89 % of admissions) were exposed to at least 1 day of unfractionated heparin (UFH) or low molecular weight heparin (LMWH). Of 346 anti-PF4 antibody assays performed, 52 (15 %) were positive. Seventeen patients (4.9 % of total) were determined to have HITS. Of these, 13 cases (76 %) were patients who were initiated on haemodialysis via central venous catheters. Five patients (29 %) subsequently experienced thrombosis. The rate of HITS in patients given UFH was 0.33 %. HITS occurred in only one patient given LMWH. Of 1337 patients with chronic renal failure initiated on long term haemodialysis, the incidence of HITS was 0.97 %. Despite increased awareness of HITS, testing frequency remains conservative. An overwhelming majority of HITS cases were diagnosed among patients initiated on haemodialysis.Entities:
Keywords: Heparin; Heparin-induced thrombocytopenia; Incidence
Mesh:
Substances:
Year: 2016 PMID: 27106479 DOI: 10.1007/s12185-016-2013-3
Source DB: PubMed Journal: Int J Hematol ISSN: 0925-5710 Impact factor: 2.490